検索に戻る
案件記録
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
発明審査中
6閲覧数
20請求項 · 7 独立
§ Ⅰ
案件概要
発明者
Hubert BORELL; Anne GARDIN; Yi JIN; Eric LEGANGNEUX; Mike UFER
IPC分類
C7D 205/4C12Q 1/6883G1N 33/50G1N 33/569
CPC分類
C7D205/4C12Q1/6883G1N33/5094G1N33/56972C12Q2600/106C12Q2600/156G1N2800/52
The invention provides a method of assessing the appropriate therapeutic dose of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid to administer to a patient in need thereof, comprising the steps of:
原文（中国語）
The invention provides a method of assessing the appropriate therapeutic dose of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid to administer to a patient in need thereof, comprising the steps of:
外部リソース